SAILIFE · NSE Healthcare Large Cap

Sai Life Sciences Limited

SAILIFE  ·  National Stock Exchange of India

SAILIFE is currently trading at ₹1,585, 13.5% above its 50-day moving average. The Kasauti methodology audit finds 8 of 8 structural parameters confirmed, placing this instrument in the Passes All Criteria category.

Data Execution Timestamp: 11 September 2026 · NSE Closing Bell
Overall Verdict
कसौटी पर खरा उतरा
Passes All Criteria
Minervini SEPA 8 / 8
Weinstein Stage Stage 2 — Advance
Base Advance Top Decline
52-Week Price History — Weekly
₹1.58k Snapshot · NSE Closing Bell · 11 Sep 2026
₹727 ₹961 ₹1.2k ₹1.4k ₹1.7k Jul '25 Oct '25 Jan '26 Apr '26 Jul '26 52W H ₹1.6k
Weekly close 50 DMA 200 DMA 52W high

Minervini SEPA — 8 Parameter Audit

Parameter Result Data
Price above 150 & 200 DMA
Minervini SEPA · Criterion 1
PASS Price ₹1,585 · 150 DMA ₹1,176 · 200 DMA ₹1,102
150 DMA above 200 DMA
Minervini SEPA · Criterion 2
PASS 150 DMA ₹1,176 vs 200 DMA ₹1,102 (+6.7%)
200 DMA trending up ≥ 1 month
Minervini SEPA · Criterion 3
PASS 200 DMA slope: +6.02% over 4 weeks
50 DMA above 150 & 200 DMA
Minervini SEPA · Criterion 4
PASS 50 DMA ₹1,396 · 150 DMA ₹1,176 · 200 DMA ₹1,102
Price above 50 DMA
Minervini SEPA · Criterion 5
PASS Price ₹1,585 · 50 DMA ₹1,396 (+13.5%)
Price within 25% of 52-week high
Minervini SEPA · Criterion 6
PASS ₹1,585 vs 52W high ₹1,697 (-6.6%)
Price ≥ 30% above 52-week low
Minervini SEPA · Criterion 7
PASS ₹1,585 vs 52W low ₹784 (+102.2%)
RS Rating ≥ 70
Minervini SEPA · Criterion 8
PASS RS Rating: 93 (threshold: ≥70)

Weinstein Stage Analysis

Stage 1
Base
Stage 2
Advance
Stage 3
Top
Stage 4
Decline

SAILIFE.NS is in Weinstein Stage 2 — the advancing phase. The 200-day moving average is trending upward, price is holding above all key moving averages, and the structure reflects institutional accumulation. This is the only stage where position traders should hold capital deployed in this instrument.

Relative Strength Rating

93 Stronger than 93% of the NSE universe
↓ Declining over 13 weeks

Structural Analysis

Sai Life Sciences Limited is currently trading 13.5% above its 50-day moving average, with Weinstein Stage 2 confirmed by the moving average hierarchy.

The Minervini SEPA audit finds 8 of 8 parameters confirmed. All criteria are satisfied.

Sanjaya's Reading

The Witness Speaks

Mitra, main dekh raha hoon Sai Life Sciences Limited ko — 8 criteria poore hain aath mein se.

Weinstein Stage 2 mein hai yeh instrument. कसौटी पर खरा उतरा.

This is a static snapshot

This audit was generated from NSE closing data on 11 September 2026. Run a live audit with real-time data, animated criteria reveals, and Sanjaya's full narration.

Run a Live Audit — Free →

Free tier includes Nifty 50 stocks · Pro unlocks full NSE universe

Frequently Asked Questions

Does SAILIFE pass the Minervini SEPA criteria?

SAILIFE (Sai Life Sciences Limited) currently meets 8 of 8 Minervini SEPA parameters. SAILIFE currently meets 8 of 8 Minervini SEPA parameters. All eight criteria are confirmed, placing this in the highest conviction tier.

What is the Weinstein Stage Analysis for SAILIFE?

SAILIFE is currently in Weinstein Stage 2. SAILIFE.NS is in Weinstein Stage 2 — the advancing phase. The 200-day moving average is trending upward, price is holding above all key moving averages, and the structure reflects institutional accumulation. This is the only stage where position traders should hold capital deployed in this instrument.

Is SAILIFE structurally aligned for position trading?

The Kasauti verdict for SAILIFE is कसौटी पर खरा उतरा (Passes All Criteria). The Kasauti verdict for SAILIFE.NS is कसौटी पर खरा उतरा — Passes All Criteria. With 8 of 8 criteria met, the stock satisfies all Minervini SEPA parameters in full. This is a structural methodology assessment only — not a recommendation to deploy or exit capital. This is a structural methodology assessment only — not a recommendation to deploy or exit capital.

Methodology Assessment Disclaimer: This page presents a systematic structural audit of SAILIFE against methodology parameters derived from the published works of Mark Minervini and Stan Weinstein. All data is sourced from NSE end-of-day prices. This content is for educational and analytical purposes only. Kasauti™ does not provide investment advice, stock recommendations, or capital deployment directives. Always conduct independent research and consult a SEBI-registered investment adviser before making any financial decisions.